Next, let’s turn to the financials. FY18 revenue of $29.953 billion grew 5 percent on a comparable, constant currency basis. FY18 non- GAAP diluted earnings per share grew 9 percent on a comparable basis, or 10 percent on a comparable, constant currency basis. The second half of the year was particularly strong, overcoming several first half challenges – including an IT disruption, multiple hurricanes, wildfires in Santa Rosa, and supply constraints in Diabetes. We delivered on our revenue and EPS guidance we established at the start of the year. We also continued to drive margin expansion, reduced debt leverage, and returned $4.3 billion to shareholders in the form of dividends and share repurchases.